Education
About Us
Working with TipRanks
Follow Us
Alkem Laboratories Ltd. (IN:ALKEM)
:ALKEM
RESEARCH TOOLSreports
Total Valuation
Alkem Laboratories Ltd. has a market cap or net worth of ₹586.74B. The enterprise value is ₹215.88B.
Market Cap₹586.74B
Enterprise Value₹215.88B
Share Statistics
Alkem Laboratories Ltd. has 119,565,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119,565,000
Owned by Insiders―
Owned by Institutions0.02%
Financial Efficiency
Alkem Laboratories Ltd.’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 13.01%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.01%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.73
Inventory Turnover1.63
Valuation Ratios
The current PE Ratio of Alkem Laboratories Ltd. is 26.70. Alkem Laboratories Ltd.’s PEG ratio is 1.34.
PE Ratio26.70
PS Ratio0.00
PB Ratio3.84
Price to Fair Value4.82
Price to FCF84.16
Price to Operating Cash Flow26.88
PEG Ratio1.34
Income Statement
In the last 12 months, Alkem Laboratories Ltd. had revenue of 129.65B and earned 21.65B in profits. Earnings per share was 181.11.
Revenue129.65B
Gross Profit82.00B
Operating Income21.55B
Pretax Income25.27B
Net Income21.65B
EBITDA30.06B
Earnings Per Share (EPS)181.11
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Alkem Laboratories Ltd. pays an annual dividend of ₹8, resulting in a dividend yield of 1.51%
Dividend Per Share₹8
Dividend Yield1.51%
Payout Ratio23.19%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change-0.12%
50-Day Moving Average5.03K
200-Day Moving Average5.30K
Relative Strength Index (RSI)49.01
Average Volume (3m)91.48K
Important Dates
Alkem Laboratories Ltd. upcoming earnings date is Aug 8, 2025, TBA (Confirmed).
Last Earnings DateMay 29, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateAug 08, 2025
Financial Position
Alkem Laboratories Ltd. as a current ratio of 2.76, with Debt / Equity ratio of 17.36%
Current Ratio2.76
Quick Ratio2.02
Debt to Market Cap0.02
Net Debt to EBITDA0.36
Interest Coverage Ratio17.71
Taxes
In the past 12 months, Alkem Laboratories Ltd. has paid 3.11B in taxes.
Income Tax3.11B
Effective Tax Rate0.12
Enterprise Valuation
Alkem Laboratories Ltd. EV to EBITDA ratio is 19.59, with an EV/FCF ratio of 47.60.
EV to Sales4.54
EV to EBITDA19.59
EV to Free Cash Flow47.60
EV to Operating Cash Flow30.79
Balance Sheet
Alkem Laboratories Ltd. has ₹22.89B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹22.89B billion.
Cash & Marketable Securities₹22.89B
Total Debt₹0.00
Net Cash-₹22.89B
Net Cash Per Share-₹191.43
Tangible Book Value Per Share₹994.92
Margins
Gross margin is 57.63%, with operating margin of 16.62%, and net profit margin of 16.70%.
Gross Margin57.63%
Operating Margin16.62%
Pretax Margin19.49%
Net Profit Margin16.70%
EBITDA Margin23.19%
EBIT Margin20.43%
Analyst Forecast
The average price target for Alkem Laboratories Ltd. is ₹4,947.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target₹4,947.50
Price Target Upside-6.04% Downside
Analyst ConsensusModerate Sell
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―